Retatrutide Availability in Canada
Retatrutide is not approved by Health Canada as of May 2026. Health Canada typically follows FDA approvals for obesity drugs, so Canadian approval would likely follow US approval by 6 to 12 months. The drug is not available through standard Canadian pharmacies or covered by provincial health plans. The only options for obtaining retatrutide in Canada are through clinical trial participation — if eligible — or through grey market research peptide vendors. Canadian customs is known to intercept shipments of unapproved pharmaceutical products, so domestic vendors are the lower-risk option.
Canadian Grey Market Vendors
Several Canadian research chemical vendors offer retatrutide as a lyophilized powder priced in Canadian dollars. A 10 mg vial typically costs CAD -150 depending on the vendor. Canadian vendors have the advantage of domestic shipping, which avoids customs delays and seizure risks. Vendors based in Vancouver and Toronto are the most common. As with all grey market purchases, verifying third-party Certificate of Analysis results before purchase is essential for quality assurance.
Leave a Reply